Inhibition of HDAC6-dependent carcinogenesis: Emerging, new therapeutic options besides belinostat

Title
Inhibition of HDAC6-dependent carcinogenesis: Emerging, new therapeutic options besides belinostat
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF CANCER
Volume 124, Issue 2, Pages 509-509
Publisher
Wiley
Online
2008-09-03
DOI
10.1002/ijc.23975

Ask authors/readers for more resources

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started